Covered recipient · General Payments record
BRUCE E GOECKERITZ
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$2,571.63
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $365.56 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $122.01 | 5 |
| ABBVIE INC. | $76.08 | 3 |
| PFIZER INC. | $44.18 | 3 |
| ANI Pharmaceuticals, Inc. | $32.45 | 1 |
| UCB, Inc. | $24.40 | 1 |
| GENZYME CORPORATION | $24.24 | 1 |
| Janssen Biotech, Inc. | $23.92 | 1 |
| Celgene Corporation | $18.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.44 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807468 | CMS |
| ABBVIE INC. | $26.18 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807470 | CMS |
| ABBVIE INC. | $28.46 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103807472 | CMS |
| Amgen Inc. | $22.56 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111585143 | CMS |
| Amgen Inc. | $30.67 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111585139 | CMS |
| Amgen Inc. | $21.43 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111585145 | CMS |
| Amgen Inc. | $30.93 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117563720 | CMS |
| Amgen Inc. | $16.42 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111585141 | CMS |
| ANI Pharmaceuticals, Inc. | $32.45 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091142208 | CMS |
| Celgene Corporation | $18.28 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101143423 | CMS |
| GENZYME CORPORATION | $24.24 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139888486 | CMS |
| Janssen Biotech, Inc. | $23.92 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078643863 | CMS |
| PFIZER INC. | $13.26 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130981768 | CMS |
| PFIZER INC. | $17.20 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131504899 | CMS |
| PFIZER INC. | $13.72 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131881953 | CMS |
| UCB, Inc. | $24.40 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143100844 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.